Clear Harbor Asset Management’s Blueprint Medicines BPMC Stock Holding History

Clear Harbor Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,581	Closed	-$331K	–	426
2025 Q2	$331K	Buy	+2,581	New	+$268K	0.02%	325
2025 Q1	–	Sell	-3,019	Closed	-$263K	–	417
2024 Q4	$263K	Sell	3,019 -81	-3%	-$7.42K	0.02%	326
2024 Q3	$287K	Hold	3,100	–	–	0.02%	301
2024 Q2	$334K	Hold	3,100	–	–	0.03%	273
2024 Q1	$294K	Hold	3,100	–	–	0.03%	294
2023 Q4	$286K	Buy	+3,100	New	+$201K	0.03%	286

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Clear Harbor Asset Management's BPMC Position: Q3 2025 in Review

Clear Harbor Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 2,581 shares — an estimated $331K sold.

Clear Harbor Asset Management first reported a position in BPMC in Q4 2023 and held it in 6 quarters. The position peaked at $334K in Q2 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Clear Harbor Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Clear Harbor Asset Management sold 2,581 Blueprint Medicines shares in Q3 2025, an estimated $331K.
Clear Harbor Asset Management first reported a position in Blueprint Medicines in Q4 2023 and held it in 6 quarters.
Clear Harbor Asset Management's Blueprint Medicines position peaked at $334K in Q2 2024.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Clear Harbor Asset Management's 13F filing for Q3 2025, filed 23 Oct 2025.